"Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient"@en . "Sharat Singh" . . . "Linda Ohrmund" . . "wetenschappelijk artikel"@nl . . . . "Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient"@en . . "Ann Gils" . "im Februar 2013 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u043B\u044E\u0442\u043E\u043C\u0443 2013"@uk . . . . . . . . "2013-02-19T00:00:00Z"^^ . . . "962-971" . "Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient"@nl . . . . . . "Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient"@nl . . . "108" . . . . . . "6" . . . . . . . . . . . . . . . . . . . "Antibody response to infliximab and its impact on pharmacokinetics can be transient"@en . . . . . . . . "article"@en . . "article scientifique publi\u00E9 en 2013"@fr . . . . "23419382" . . . "Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient"@nl . . "10.1038/AJG.2013.12" . . . "Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient"@en . .